Coronary bifurcations are encountered in about 15 - 20% of percutaneous coronary interventions (PCI). They are considered technically challenging and associated with worse clinical outcomes than non-bifurcation lesions. Percutaneous coronary intervention (PCI) to the target bifurcation lesion. Randomization (by means envelope randomization) to investigational device: Group 1 for BiOSS LIM C implantation vs Group 2 for any DES implantation.
Single stent implantation in the main vessel-main branch across a side branch is the default strategy (provisional T-stenting, PTS) in all patients enrolled. Bifurcation lesions are assessed according to Medina classification using an index of 1 for stenosis greater than 50% and 0 for no stenosis (visual estimation). There is no restriction regarding lesion length in patient selection. If required, additional stent can be implanted (Alex Plus in the BiOSS Lim C Group). A stent in a side branch (Alex Plus in the BiOSS Lim C Group) should be implanted only if there is proximal residual stenosis greater than 70% after balloon dilatation and/or significant flow impairment after main vessel - main branch stenting and/or a flow limiting dissection. The implantation protocol for bifurcation is as follows: 1. wiring of both branches; 2. main vessel predilatation and/or side branch predilatation according to the operator's decision; 3. stent implantation (inflation for at least 20 s); 4. proximal optimization technique (POT) 5. side branch postdilatation/side branch stent implantation if necessary 6. final kissing balloon inflation at operator's discretion. 7. Second proximal optimization technique (re-POT)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
518
PCI with BiOSS LIM C or rDES depending on the randomization
Department of Invasive Cardiology Central Clinical Hospital of the Ministry of Interior
Warsaw, Poland
RECRUITINGMACE
Major Cardiovascular Events rate (cardiac death, myocardial infarction, target lesion revascularization);
Time frame: 12 months
All cause death
All cause death
Time frame: 12 months
cardiac death
cardiac death
Time frame: 12 months
myocardial infarction
myocardial infarction
Time frame: 12 months
target lesion revascularization
target lesion revascularization
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.